BioSpace News Archive

Business

Dianthus Therapeutics Strengthens Leadership Team with Appointment of Susan Kalled, Ph.D., as Chief Scientific Officer

Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today announced the appointment of Susan Kalled, Ph.D., as Chief Scientific Officer.

January 17, 2023
·
3 min read
Business

Incyte to Report Fourth Quarter and Year-End 2022 Financial Results

Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2022 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 7, 2023.

January 17, 2023
·
1 min read
BioMidwest

MAIA Biotechnology Advances New Telomere-Targeting Molecule Program

MAIA Biotechnology, Inc. (NYSE American: MAIA ) announced today the advancement of its Telomere-Targeting Molecule Program (“Project T3”).

January 17, 2023
·
5 min read
Business

Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader

Catalent, Inc. today announced the appointment of Ricardo Zayas as Senior Vice President, Operations, Biologics North America.

January 17, 2023
·
3 min read
Lone Star Bio

Lantern Pharma Receives Pre-IND Feedback from the FDA, Clearing a Path for Drug Candidate LP-184’s Phase 1 Clinical Trial in Q2 2023

Lantern Pharma Inc. today announced it has received guidance from the United States Food and Drug Administration (FDA) on Lantern’s clinical development plans for its LP-184 program.

January 17, 2023
·
6 min read
Genetown

Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series

Pear Therapeutics, Inc. today announced the company will participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series on Tuesday, January 24 at 11:00 a.m. ET.

January 17, 2023
·
1 min read
Lone Star Bio

Natera Announces Publication of Prospective, Multi-Site CIRCULATE Study in Nature Medicine Demonstrating Signatera’s Ability to Predict Chemotherapy Benefit in Colorectal Cancer

Natera Announces Publication of Prospective, Multi-Site CIRCULATE Study in Nature Medicine Demonstrating Signatera’s Ability to Predict Chemotherapy Benefit in Colorectal Cancer.

January 17, 2023
·
5 min read
Business

CorMedix Inc. Announces Promotions in Commercial and Tech Ops

CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, announced the following promotions within the organization:

January 17, 2023
·
5 min read
Business

TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology

TC Biopharm today announces a strategic collaboration with The University of Texas MD Anderson Cancer Center to expand the knowledge base of how gamma-delta T cells work in oncology settings.

January 17, 2023
·
3 min read
BioMidwest

Commonwealth Dermatology Is First in Massachusetts to Offer Non-Surgical Treatment for Common Skin Cancers

SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most advanced non-surgical technology for the treatment of common skin cancers, today announced the availability of the technology in Massachusetts.

January 17, 2023
·
2 min read